Skip to content
GenoLensGenoLens

ALDH4A1

Chr 1p36.13

aldehyde dehydrogenase 4 family member A1

Aliases:
P5CDh
MANE:
ENST00000375341.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Likely inborn error of metabolism

    BIALLELIC, autosomal or pseudoautosomal
  • Undiagnosed metabolic disorders

    BIALLELIC, autosomal or pseudoautosomal
  • Childhood onset dystonia, chorea or related movement disorder

  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • hyperprolinemia type 2

    0.79
  • Intellectual disability

    0.50
  • hyperprolinemia

    0.37
  • spermatocele

    0.29
  • Seizure

    0.15
  • alcohol drinking

    0.13
  • MHC class II deficiency

    0.12
  • Immunodeficiency by defective expression of HLA class 2

    0.12
  • urolithiasis

    0.12
  • hypothyroidism

    0.07

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial

Irreversible conversion of delta-1-pyrroline-5-carboxylate (P5C), derived either from proline or ornithine, to glutamate. This is a necessary step in the pathway interconnecting the urea and tricarboxylic acid cycles. The preferred substrate is glutamic gamma-semialdehyde, other substrates include succinic, glutaric and adipic semialdehydes

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.